Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic Vaccine
Clinical trial NCT00562237 · TERMINATED
Trial details
- NCT number
- NCT00562237
- Sponsor
- Solvay Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2007-11-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.